Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program.
about
BabesiosisNatural history of Zoonotic Babesia: Role of wildlife reservoirsA review of piroplasmid infections in wild carnivores worldwide: importance for domestic animal health and wildlife conservationApheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patientCost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States.Sequence and annotation of the apicoplast genome of the human pathogen Babesia microti.Babesia: an emerging infectious threat in transfusion medicineSensitive multiplex PCR assay to differentiate Lyme spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti.Babesiosis Occurrence among the Elderly in the United States, as Recorded in Large Medicare Databases during 2006-2013Multiplex assay detection of immunoglobulin G antibodies that recognize Babesia microti antigens.A longitudinal study of Babesia microti infection in seropositive blood donorsBabesia microti infection, eastern Pennsylvania, USA.Molecular diagnosis in clinical parasitology: when and why?Adverse effects of transfusion.Transfusion-transmitted babesiosis: is it time to screen the blood supply?Transfusion-transmitted babesiosis leading to severe hemolysis in two patients with sickle cell anemia.Transfusion-associated Anaplasma phagocytophilum infection in a pregnant patient with thalassemia trait: a case report.Transfusion-transmitted anaplasmosis from leukoreduced red blood cells.Seroprevalence of Babesia microti infection in Canadian blood donors.Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.A targeted immunomic approach identifies diagnostic antigens in the human pathogen Babesia microti.Diagnosis and management of human babesiosis.Cost-effectiveness of Babesia microti antibody and nucleic acid blood donation screening using results from prospective investigational studies.Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supply.Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States.Babesia microti seroprevalence in Minnesota blood donors.Babesia microti real-time polymerase chain reaction testing of Connecticut blood donors: potential implications for screening algorithms.PERFORMANCE EVALUATION OF A PROTOTYPE ARCHITECT ANTIBODY ASSAY FOR BABESIA MICROTI.Efficient detection of symptomatic and asymptomatic patient samples for Babesia microti and Borrelia burgdorferi infection by multiplex qPCR.
P2860
Q26829108-EC9068A3-2CA1-4276-B8B8-6D5FD1B6C5C6Q27002385-2FC01860-2817-4B44-8ACC-4FBE7847A54EQ28076451-417AF777-238C-42FC-8CAA-11FBC84B7161Q30252073-A20F4E7C-BA03-4408-8F57-12B9D28AD329Q33601255-B2E9AF00-C054-4233-BA58-D5678A7749DAQ33688664-AF84E647-3F98-4E3C-A086-31800798193EQ34287077-5183031D-CA94-4DBB-93D7-B6BBE0F56E8FQ34819404-927D071D-25D5-4764-8F17-7F291B47088FQ35073777-4C0C66FF-9D16-4822-B5F0-E1130E3BAFAAQ35808739-74E55A84-284A-49E0-B189-F2F332E6A411Q36191682-C97B46E7-5A75-4B2C-A621-8E5E33D5A883Q36635870-16AAB6FC-E1D5-409A-B277-736BF44056B0Q37021083-129E462C-DD92-493F-8749-F0B3727BD20EQ38199443-F09F1CA3-20E5-4603-9B7D-A1E142FC0C2BQ38287593-115F0EC7-76D7-448C-AC16-29530FAEB5E4Q38930826-F9F20DF3-2CDD-4D64-929B-317E53BDCBD8Q40110167-D7BD3E22-5882-4481-B201-09D79A4A44B8Q40183467-EA46BEC1-04B0-49A3-A34E-07BCF0C56FD7Q40287912-F5BEEF49-0F13-4C0D-BEEA-73CE5D15B05AQ40478505-7F8E1CCA-1FF3-4818-A1D3-3F0659F7A493Q40611312-AF85BACE-5085-4301-9B0A-7423FFBEC637Q40672654-9728B1CC-3063-4B3A-BB7F-252EB44EBEBAQ40886087-5EA6E554-AD5A-4B12-8A4D-6EF980666179Q41212097-C76D0276-C2D1-429E-BF82-6CA2B80CEA33Q42202498-D34D5AFB-23DE-4EBA-8E25-1AA6FC5C97AFQ42213563-2E56A24F-4378-4525-8513-13CB2A893080Q43706156-41F04CE0-9D20-4DD6-9E47-4628E33D0FA6Q50494525-19292F78-4FC3-4F3A-8FC5-4F0E5F709574Q54216856-964D8877-849C-4FEB-9F84-7E99F7C1BF5BQ55354078-1848B706-B62A-4A12-888E-2C1C6E79FEA8
P2860
Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Preventing transfusion-transmi ...... blood donor screening program.
@en
Preventing transfusion-transmi ...... blood donor screening program.
@nl
type
label
Preventing transfusion-transmi ...... blood donor screening program.
@en
Preventing transfusion-transmi ...... blood donor screening program.
@nl
prefLabel
Preventing transfusion-transmi ...... blood donor screening program.
@en
Preventing transfusion-transmi ...... blood donor screening program.
@nl
P2093
P2860
P1433
P1476
Preventing transfusion-transmi ...... blood donor screening program.
@en
P2093
Anjulika Chawla
Babesia Testing Investigational Containment Study Group
Carolyn Young
Gail Skowron
James Padbury
Peter J Krause
Victor Berardi
P2860
P304
P356
10.1111/J.1537-2995.2012.03612.X
P577
2012-03-27T00:00:00Z